RNA sequencing is vital for cutting-edge cancer diagnostics, pharmaceutical development, and food security, but the time and cost are major bottlenecks. At Amaryllis Nucleics, our technology breaks down these barriers by cutting time and cost manyfold — empowering researchers and accelerating impor
Mentions in press and media 2
| Date | Title | Description |
| 13.09.2016 | Amaryllis Nucleics makes transcribing genes quicker, better and cheaper | The ability to read and record genes sits at the base (base pair, if you will) of biotech companies worldwide. So improvements to that ability are kind of like upgrading the specs of the industry itself. That’s what Amaryllis Nucleics aims ... |
| 12.07.2016 | Watch the Indiebio Demo Day here | TechCrunch is pleased to bring you Indiebio’s Demo Day this Thursday, July 14th from San Francisco. Backed by SOSV, Indiebio is the largest life sciences accelerator to date. Indiebio provides each startup in the accelerator with $250,000, ... |